Multi-centre, open label, randomized phase I/II clinical of the use of REX-002 in chronic critical limb ischemia non-diabetes patients
Latest Information Update: 08 Feb 2022
At a glance
- Drugs REX 002 (Primary)
- Indications Chronic limb-threatening ischemia
- Focus Adverse reactions; Therapeutic Use
- 10 Aug 2016 New trial record